Clinical Trials

Inclusion Criteria:

• Inclusion criteria for the study includes a convenience sample of adult ICU patients with 2 or more identified risk factors with admission to ICU for 48 hours or longer. References for the risk factors are in the Study Protocol. Risk factors include the following:
  • 2 or more organ system failures as defined by:
    • Cardiac (Mechanical Cardiac Assist Devices);
    • Renal (Continuous Renal Replacement Therapy (CRRT);
    • Respiratory (Mechanical Ventilation);
    • Liver (Model for End-Stage Liver Disease (MELD) Score > 20)
  • 2 or more Vasoactive and inotrope medications infusions at time of enrollment:
    • Dobutamine;
    • Epinephrine;
    • Dopamine;
    • Milrinone;
    • Phenylephrine;
    • Norepinephrine;
    • Vasopressin.
• Peripheral Arterial Disease listed on active problem list
• Extracorporeal Membrane Oxygenation (ECMO) Support
• Mechanical Ventilation for greater than 72 hours
• Documented Sepsis or Septic Shock in Electronic Health Record

Exclusion Criteria: 

• Patients with a pressure injury present on admission.
• Patients admitted to the ICU less than 48 hours.
• Patients with a provider “do not turn” order.
• Patients under 18 years of age.
• Patients not currently ICU status level of care.
• Patients that cannot be assessed by devices due to technological limitations.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 4/25/23. Questions regarding updates should be directed to the study team contact.